Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gilles L. Fraser, PharmD"'
Autor:
Ji Tong Liu, PharmD, BCCCP, Caitlin S. Brown, PharmD, BCCCP, FCCM, Kristin C. Mara, MS, Richard R. Riker, MD, FCCM, Alejandro A. Rabinstein, MD, Gilles L. Fraser, PharmD, MCCM, Teresa L. May, DO, Kaitlin J. Armstrong, PharmD, David B. Seder, MD, FCCM, David J. Gagnon, PharmD, BCCCP, FCCM
Publikováno v:
Critical Care Explorations, Vol 5, Iss 10, p e0987 (2023)
IMPORTANCE:. Protein binding of valproate varies among ICU patients, altering the biologically active free valproate concentration (VPAC). Free VPAC is measured at few laboratories and is often discordant with total VPAC. Existing equations to predic
Externí odkaz:
https://doaj.org/article/e1a61f73edfc455a9251a6987de219bf
Autor:
Caitlin S. Brown, PharmD, BCCCP, JiTong Liu, PharmD, Richard R. Riker, MD, FCCM, Kristin C. Mara, MS, Alejandro A. Rabinstein, MD, Gilles L. Fraser, PharmD, MCCM, Teresa L. May, DO, David Seder, MD, FCCM, David J. Gagnon, PharmD, BCCCP, FCCM
Publikováno v:
Critical Care Explorations, Vol 4, Iss 9, p e0746 (2022)
OBJECTIVES:. Protein binding of valproate is variable in ICU patients, and the total valproate concentration does not predict the free valproate concentration, even when correcting for albumin. We sought to quantify valproate free concentration among
Externí odkaz:
https://doaj.org/article/5e2eb64f2e1a4d12a80007a6f889f3af
Autor:
Chelsea Wampole, PharmD, Ariel McKenna, DO, Richard R. Riker, MD, Teresa L. May, DO, David B. Seder, MD, Dawn Abram, MS, Gilles L. Fraser, PharmD, David J. Gagnon, PharmD
Publikováno v:
Critical Care Explorations, Vol 4, Iss 7, p e0735 (2022)
OBJECTIVES:. The association between opioid therapy during critical illness and persistent opioid use after discharge is understudied relative to ICU opioid exposure and modifiable risk factors. Our objectives were to compare persistent opioid use af
Externí odkaz:
https://doaj.org/article/d54c00d10be74d53a0ff8d5f8419cf1a